Form 4 for DGX Quest Diagnostics
Accepted 2024-02-27 00:00:00 ET · period of report 2024-02-23 · accession 0001022079-24-000066 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-27 | 2024-02-23 | DGX | PREVOZNIK MICHAEL E | SVP, GC | A - Grant | $125.02 | +7,569 | 47.8K | +19% | +$946.3K | |
| 2024-02-27 | 2024-02-23 | DGX | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $125.02 | -2,825 | 45.0K | -6% | -$353.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-23 | A | A | 7,569 | $125.02 | 47,775 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-23 | F | D | 2,825 | $125.02 | 44,950 | D | — | — |